Congenital hypothyroidism (CH) may be caused by biallelic variants in the TSHR gene. CH due to thyroid dysgenesis has also been linked to pathogenic variants of the nucleotide kinase 2, homeobox 5 (NKX2-5) gene, which can also cause sudden cardiac death from ventricular arrhythmia. In particular, the NKX2-5 p.Arg25Cys missense variant has been repeatedly reported in patients with congenital heart defects and, more rarely, with hypogonadism. We report the case of a 7 year old boy with ventricular arrhythmias, thyroid dysgenesis and intellectual disability, born from consanguineous Tunisian parents. Exome sequencing and segregation analysis revealed two potentially relevant variants: the NKX2-5 p.Arg25Cys variant (maternally inherited), as well as a single heterozygous TSHR p.Gln90Pro variant (paternally inherited). Of note, a male sibling of the proband, presenting with intellectual disability only, carried the same two variants. No other TSHR variants, or other potentially relevant variants were identified. In this proband, despite the identification of variants in two genes potentially correlated to the phenotype, a definite genetic diagnosis could not be reached. This case report highlights the complexity of exome data interpretation, especially when dealing with families presenting complex phenotypes and variable expression of clinical traits.
Case Report • Arch. Endocrinol. Metab. 67
(1)
• Feb 2023 • https://doi.org/10.20945/2359-3997000000546 linkcopy
A young boy with ventricular arrhythmias and thyroid dysgenesis: two genes are not enough?
Authorship
followed the patients up · drafted the manuscript · critically reviewed and edited the manuscript, and approved the final version as submitted
person Evelina Maines
critically reviewed and edited the manuscript, and approved the final version as submitted
person Maria Bellizzi
followed the patients up · critically reviewed and edited the manuscript, and approved the final version as submitted
person Francesca Rivieri
followed the patients up · critically reviewed and edited the manuscript, and approved the final version as submitted
person Andrea Bacca
critically reviewed and edited the manuscript, and approved the final version as submitted
person Alessandra Filippi
followed the patients up · critically reviewed and edited the manuscript, and approved the final version as submitted
person Enza Maria Valente
performed genetic studies · critically reviewed and edited the manuscript, and approved the final version as submitted
schoolNeurogenetics Research Center, IRCCS Mondino Foundation, Pavia, ItalyIRCCS Mondino FoundationItalyPavia, ItalyNeurogenetics Research Center, IRCCS Mondino Foundation, Pavia, ItalyschoolDepartment of Molecular Medicine, University of Pavia, Pavia, ItalyUniversity of PaviaItalyPavia, ItalyDepartment of Molecular Medicine, University of Pavia, Pavia, Italy
person Massimo Plumari
performed genetic studies · critically reviewed and edited the manuscript, and approved the final version as submitted
person Massimo Soffiati
critically reviewed and edited the manuscript, and approved the final version as submitted
person Monica Vincenzi
drafted the manuscript · critically reviewed and edited the manuscript, and approved the final version as submitted
person Francesca Teofoli
drafted the manuscript · critically reviewed and edited the manuscript, and approved the final version as submitted
person Marta Camilot
drafted the manuscript · critically reviewed and edited the manuscript, and approved the final version as submitted
Correspondence to: Roberto Franceschi Division of Pediatrics, S. Chiara Hospital Largo Medaglie d’Oro, 9,
38122, Trento, Italy
emailroberto.franceschi@apss.tn.it
38122, Trento, Italy
emailroberto.franceschi@apss.tn.it
Disclosure: no potential conflict of interest relevant to this article was reported.
SCIMAGO INSTITUTIONS RANKINGS
Pediatric Department, S. Chiara Hospital of Trento, Trento, ItalyS. Chiara Hospital of TrentoItalyTrento, ItalyPediatric Department, S. Chiara Hospital of Trento, Trento, Italy
Genetic Unit, S. Chiara Hospital of Trento, Trento, ItalyS. Chiara Hospital of TrentoItalyTrento, ItalyGenetic Unit, S. Chiara Hospital of Trento, Trento, Italy
Cardiology Unit, S. Chiara Hospital of Trento, Trento, ItalyS. Chiara Hospital of TrentoItalyTrento, ItalyCardiology Unit, S. Chiara Hospital of Trento, Trento, Italy
Pediatric Neuropsychology Unit, Azienda Provinciale per i Servizi Sanitari del Trentino, Trento, ItalyAzienda Provinciale per i Servizi Sanitari del TrentinoItalyTrento, ItalyPediatric Neuropsychology Unit, Azienda Provinciale per i Servizi Sanitari del Trentino, Trento, Italy
Neurogenetics Research Center, IRCCS Mondino Foundation, Pavia, ItalyIRCCS Mondino FoundationItalyPavia, ItalyNeurogenetics Research Center, IRCCS Mondino Foundation, Pavia, Italy
Figures | Tables
imageFigure 1 On the ECG at 7 years and 3 month of age (Figure 1A), there was a large QRS tachycardia, right bundle branch block and left anterior hemiblock. One month later (Figure 1B), he presented again ventricular fascicular tachycardia. open_in_new

imageFigure 2 Pedigree of the family harboring the c.73C>T mut. in NKX2.5 gene. The index patient is indicated by an arrow. Squares: male; circles: female; the transmission of the NKX2.5 variant is shown by a filled black area within each symbol, whereas the segregation of TSHR variant by a corresponding grey area. Results of thyroid and heart investigations are aligned with each symbol. open_in_new

table_chartTable S1
Previously reported patients and controls with the NKX2-5 p.Arg25Cys variant – Allelic frequencies are reported
| References | Cardiac and/or thyroid anomaly | No. of patients carryng R25C | Family history | Other family members with R25C | No. Of control patients carryng R25C | |
|---|---|---|---|---|---|---|
| Benson DW et al. (1999) (21) | TOF and VSD/no thyroid data | 1/7 | negative | not reported | 0/50 | |
| Goldmuntz E et al. (2001) (15) | TOF/no thyroid data | 3/114 (1,3%) | 1 father: ASD | 1 father | 2/43 Africans Americans (2,3%) | |
| McElhinney DB et al. (2003) (19) | 7/608 (0,58%)no thyroid data | TOF Truncus arteriosus Interrupted aortic arch HLHS |
1 1 1 1 |
father: VSD negative negative negative |
not reported negative negative negative |
0/50 randomcontrol Caucasian |
| Akcaboy MI et al. (2008) (16) | TOF/no thyroid data | 1/72 (0,69%) | negative | father | 2/185 Turkish (0,54%) | |
| Stallmeyer B et al. (2010) (20) | HLHS/no thyroid data | 1/121 (0,41%) | negative | negative | 0/380 Caucasian | |
| Perera JL et al. (2010) (4) | TOF/no thyroid data | 1/159 (0,31%) | sister: VSD | brother | 0/162 Brazilian | |
| Rauch R et al. (2010) (22) | TOF/no thyroid data | 2/230 (0,43%) | negative | negative | not tested | |
| Beffagna G et al. (2013) (23) | 2/100 (1%) | CoA, AVSD | 1/100 | negative | mother | 0/250 Italian |
| No thyroid defect | ||||||
| ASD, VSD | 1/100 | negative | not tested | |||
| Trisomy 21 | ||||||
| No thyroid defect | ||||||
| Dentice M et al. (2006) (7) | 2/241 (0,41%) | Thyroid ectopy TSH 300 mU/L, FT4 5.4 pg/mL No cardiac malformation | 1/241 | negative | mother | 1/561 (0,09%) |
| Athyreosis | 1/241 | negative | father and brother | |||
| TSH 419 mU/L, FT4 1.6 pg/mL | ||||||
| No cardiac malformation | ||||||
| Bilateral cortex atrophy | ||||||
| Attention deficit hyperactivity disorder | ||||||
| Khatami M et al. (2017) (8) | 2/65 (1,5%) | Thyroid hypoplasia TSH 17 mU/L, FT4 1.3 pg/mL No cardiac malformation | 1/65 | negative | negative | 0/62 Iranian |
| Thyroid hypoplasia TSH 21 mU/L, FT4 1.1 pg/mL No cardiac malformation | 1/65 | negative | negative | |||
| Pulignani S et al. (2018) (24) | TOF no thyroid data | 1/17 | negative | negative | not tested | |
| Alcantara-Ortigoza MA et al. (2021) (25) | 1 | Trisomy 21 and normal heart | 3/148 | negative | mother | 1/113 Mexican |
| 1 | Trisomy 21 and perimembranous VSD and PDA | father | ||||
| 1 | Trisomy 21 and complete AVSD | mother negative, father not tested | ||||
| In this study | 1 | Ventricular arrhythmias, no cardiac malformation Thyroid hemiagenesis. TSH 740 mU/L, FT4 0.9 pmol/L Intellectual disability |
1 | brother: intellectual disability | mother | not tested |
-
TOF: tetralogy of Fallot; VSD: ventricular septal defect; ASD: atrial septal defect; AVSD: atrioventricular septal defect; HLHS: hypoplastic left heart syndrome; CoA: aortic coartation. TSH normal range (0.35-4.5 mU/L), FT4 normal range (7.5-17.0 pg/mL, 12-22 pmol/L).
How to cite
location_on
Sociedade Brasileira de Endocrinologia e Metabologia
Rua Botucatu, 572 - Conjuntos 81/83, CEP: 04023-061 , Tel: +55 (11) 5575-0311 / +55 (11) 9 9768-6933 -
São Paulo -
SP -
Brazil
E-mail: aem.editorial.office@endocrino.org.br
E-mail: aem.editorial.office@endocrino.org.br
rss_feed
Acompañe los números de esta revista en su lector de RSS
Versão para download de PDF
Artículos relacionados
Lista de links para artigos relacionados. Os links abrem em nova aba.
Versões e tradução automática
Escolha a versão original do texto ou utilize um serviço de tradução automática.
Versão original do texto
Como citar
Escolha um formato para exportar ou selecione um estilo de citação. O conteúdo abaixo pode ser atualizado após a seleção.
Thumbnail
Thumbnail